Wakefield Asset Management LLLP Invests $1.02 Million in Phibro Animal Health Co. (NASDAQ:PAHC)

Wakefield Asset Management LLLP bought a new stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 48,570 shares of the company's stock, valued at approximately $1,020,000. Wakefield Asset Management LLLP owned 0.12% of Phibro Animal Health at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Quantbot Technologies LP purchased a new stake in shares of Phibro Animal Health in the third quarter worth about $70,000. China Universal Asset Management Co. Ltd. lifted its stake in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company's stock worth $88,000 after purchasing an additional 1,522 shares in the last quarter. New York State Teachers Retirement System boosted its holdings in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares during the period. Zacks Investment Management purchased a new position in shares of Phibro Animal Health during the 3rd quarter valued at $274,000. Finally, SG Americas Securities LLC increased its holdings in shares of Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after purchasing an additional 906 shares during the period. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Price Performance

Shares of PAHC traded down $0.41 during midday trading on Tuesday, reaching $24.11. The stock had a trading volume of 311,250 shares, compared to its average volume of 240,738. The company has a market capitalization of $976.53 million, a price-to-earnings ratio of 50.09, a price-to-earnings-growth ratio of 0.45 and a beta of 0.52. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a 12-month low of $11.98 and a 12-month high of $26.55. The company's 50-day moving average is $22.30 and its 200 day moving average is $22.39.

Remove Ads

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.99%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health's dividend payout ratio is presently 100.00%.

Wall Street Analyst Weigh In

Several research firms recently commented on PAHC. StockNews.com cut Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, February 6th. Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. Finally, Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $21.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.